Breast SPORE lands NCI renewal Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). The SPORE grant renewal will provide more than $11.3 million in funding support over the next five years for breast cancer research. “It is becoming uncommon for a […]
Arteaga to lead major new cancer research initiatives Carlos Arteaga, M.D., Donna S. Hall Professor of Breast Cancer, has been appointed to lead two newly created cancer research initiatives at the Vanderbilt-Ingram Cancer Center. He has been named the founding director of the Center for Cancer Targeted Therapies (CCTT) and director of the Vanderbilt-Ingram Cancer […]
Arteaga to lead American Association for Cancer Research Carlos Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt, has been elected president-elect of the American Association for Cancer Research for 2013-2014. Elected by the organization’s members, Arteaga will work with the AACR board of directors and the 34,000-plus membership to further the AACR’s mission […]
New chair of Cell and Developmental Biology named Ian Macara, Ph.D., recently joined the faculty as the new chair of the Vanderbilt Department of Cell and Developmental Biology. Macara, who was also named the Louise B. McGavock Professor, succeeds Susan Wente, Ph.D., associate vice chancellor for Health Affairs and senior associate dean for Biomedical Sciences, […]
Vanderbilt Mourns Loss of Frances Williams Preston Frances Williams Preston, one of the most successful female music executives in the history of the entertainment industry, and a member of the Vanderbilt-Ingram Cancer Center Board of Overseers, died from congestive heart failure at her home in Nashville, surrounded by her family, Wednesday, June 13. She was […]
Pao to lead Hematology and Oncology William Pao, M.D., Ph.D., Ingram Associate Professor of Cancer Research and director of Personalized Cancer Medicine at Vanderbilt, has been named director of the Division of Hematology and Oncology in the Department of Medicine. Pao completed his undergraduate education at Harvard University and his medical and graduate education at Yale University […]
Neuss Named Chief Medical Officer Michael Neuss, M.D., has been appointed chief medical officer for Vanderbilt-Ingram Cancer Center’s clinical enterprise. He assumes the newly created position July 1. A Duke-trained oncologist in practice since 1986, Neuss was, until December, the vice president of the largest oncology practice in the Cincinnati area. Neuss will report to […]
Cancer Center’s NCI support grant renewed Vanderbilt-Ingram Cancer Center has been awarded a five-year renewal of its Cancer Center Support Grant (CCSG) from the National Cancer Institute. Under the NCI’s Cancer Center Support Grant Program, VICC will receive more than $6.2 million a year for the next five years. The total represents a 12.7 percent […]
Busting myths about cancer clinical trials Using elements of “Jeopardy,” “Saturday Night Live” and the Discovery Channel show “MythBusters,” Vanderbilt cancer survivors and researchers have developed an entertaining program to skewer myths about cancer clinical trials. The educational project, “Mythbusters: Cancer Research in Jeopardy,” was presented recently by Vanderbilt-Ingram Cancer Center Research Advocates and members […]
